Search for Clinical Trial Results
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - 103 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study Condition:
Date: 2012-04-25 Interventions: Other: Observational Observational study of subjects previously enrolled in the RAVE trial |
Completed |
Study Name: Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis Condition:
Date: 2006-02-16 Interventions: Drug: Rituximab |
Active, not recruiting |
Study Name: Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis Condition:
Date: 2014-06-19 Interventions:
|
Active, not recruiting |
Study Name: Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Condition: Vasculitis Date: 2005-08-09 Interventions: Drug: azathioprine azathioprine 2 mg/kg oral once daily, duration according to arm |
Completed |
Study Name: Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides Condition:
Date: 2015-06-10 Interventions: Other: blood specimen blood specimen for serum rituximab level and serum anti-rituximab level at M1 and |
Recruiting |
Study Name: Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA) Condition:
Date: 2005-02-14 Interventions:
|
Recruiting |
Study Name: Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) Condition:
Interventions: |
Completed |
Study Name: Efficacy Study of Two Treatments in the Remission of Vasculitis Condition:
Date: 2008-09-05 Interventions:
|
Completed |
Study Name: Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis Condition:
|